Concepedia

Publication | Closed Access

Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double‐Blind, Placebo‐Controlled Study

DOI

155

Citations

13

References

2002

Year

Paul Winner, Donald W. Lewis, W. Hester Visser, Kaihong Jiang, S. Ahrens, Judith K. Evans, On Behalf Of The Rizatriptan Adolescent Study Group
Headache The Journal of Head and Face Pain

Abstract

Rizatriptan 5 mg was well tolerated and effective on some measures when used in adolescents for the treatment of a migraine attack.

References

YearCitations

Page 1